The consumer arm of British pharmaceutical major GlaxoSmithKline (GSK) is relaunching its largest brand Horlicks for the third time in four years as competitive pressures as well as a slowdown in category growth compel it to look for new customers ... Sify, 1 week ago
3 Top Growth Plays That Could Smash The FTSE 100: ARM Holdings plc, GlaxoSmithKline plc & Diageo plc
With the S&P 500 hitting record highs, 2014 has been something of a disappointment for the FTSE 100 . Indeed, the index is up just 1% since the turn of the year, but does seem to have huge potential over the medium term. That's because it trades on ...Motley Fool UK, 4 days ago
It is entering the e-tailing arena with a dedicated last-mile delivery vertical Press Trust of India | Mumbai August 10, 2014 Last Updated at 16:56 IST With Flipkart, Amazon, Snapdeal and the like hogging headlines for months, the Rs 520-crore Patel ...Business Standard India, 3 weeks ago
Economy The IMF praised the formation of the New Development Bank and reserves fund launched by BRICS countries (Brazil, Russia, India, China and South Africa) yesterday, and announced that it would like to work together with the monumental ...Seeking Alpha, 1 month ago
BANGALORE/MUMBAI: India's largest alcoholic beverage manufacturer United Spirits (USL), formerly owned by Vijay Mallya's UB Group, is now safely back in the hands of the British. Drinks giant Diageo, with its headquarters in London, has increased ...Times of India, 2 months ago
Infosys, India’s second largest software services company, expects the recent spate of mergers and acquisitions in the global pharmaceutical sector to boost its life sciences business over the next 12 months. “There is a lot of M&A activity happening in the life sciences space. "When M&A is typically initiated, budgets are tightly controlled, because companies are hoarding cash to ward off (rival bids) and to make the sale happen,” said Manish Tandon, senior ...Rediff.com, 2 months ago
Psychosocial Predictors of Non-Adherence and Treatment Failure in a Large Scale Multi-National Trial of Antiretroviral Therapy for HIV: Data from the ACTG A5175/PEARLS Trial
Abstract Background PEARLS, a large scale trial of antiretroviral therapy (ART) for HIV (n = 1,571, 9 countries, 4 continents), found that a once-daily protease inhibitor (PI) based regimen (ATV+DDI+FTC), but not a once-daily non-nucleoside ...Plosone.org, 1 week ago
Contify is a New Delhi based product company focused in the areas of machine learning, artificial intelligence, and natural language processing. Their flagship product is an enterprise grade competitive intelligence (CI) platform delivered through a ...Yourstory.in, 1 week ago
Which drugmaker should you buy? US predators are pouncing on British pharma firms - should you enter the fray?
Published: Takeover targets: Astra and Shire received controversial bids from big US rivals Britain's big three drugmakers have become embroiled in some messy controversies of late. AstraZeneca successfully , but only after a public scrap ...This is Money, 2 weeks ago
(Updates with 2012 study in 39th paragraph.) Aug. 11 (Bloomberg) -- The chemical triclosan has been linked to cancer-cell growth and disrupted development in animals. Regulators are reviewing whether it's safe to put in soap, cutting boards and ...Washington Post, 3 weeks ago Colgate Total Component's Link Spotlights FDA Process Washington Post, 3 weeks ago Total recoil: toothpaste may be carcinogenic The Financial Chronicle, 3 weeks ago Colgate Total Ingredient Linked to Hormones, Cancer Spotlights FDA Process Bloomberg, 3 weeks ago
More from: , Moneynews...and 7 other sources
on your WebpageAdd Widget >Get your members hooked!